applelatest, Author at Apple Latest - Page 75 of 100
Home Customized
applelatest

applelatest

Shares of AngioDynamics, which specializes in therapeutic devices, soar on optimistic 2024 outlook

On Thursday, the U.S. Food and Drug Administration (FDA) granted 510(k) clearance for AngioDynamics' (NASDAQ: ANGO) AlphaVac F1885 system for the treatment of pulmonary embolism (PE). The expanded FDA indication allows the use of the AlphaVac F1885 System for the treatment of pulmonary embolism, expanding the applicability of the AlphaVac F1885 System for the non-surgical removal of thrombus or embolus from venous blood vessels. The indication expands treatment options for PE patients, reduces thrombus burden, and improves right ventricular function. It also includes

Wells Fargo Thinks It's "Time to Buy" These Two Stocks

With a full quarter of 2024 behind us, it's clear that we are in the midst of another bull run, similar to last year's. The market bottomed in October 2023 and the S&P 500 has rallied 24.5% since then. The market bottomed out in October 2023, and since then the S&P 500 has risen 24.5% and the NASDAQ Resonance Index has bounced back 29%. Year-to-date, the two indexes have risen 9% and 10% respectively, and while last year's rally was largely based on a narrow uptick in the megacorporation of tech companies, this year's rally has been based on a much wider base, offering investors more investment opportunities. This year's rally is based on a broader base, providing investors with more investment opportunities.

How to Earn $500 a Month from Greenbrier Companies Stock Before Q2 Earnings Release

Greenbrier Companies, Inc. (NYSE: GBX) will release its second-quarter financial results on April 5, 2024, before rock bottom. Analysts expect the Lake Oswego, Oregon-based company to report second-quarter earnings of 86 cents per share, down from 99 cents in the year-ago quarter. According to Benzinga Pro, Greenbrier was expected to report quarterly revenue of $843.28 million, and on Jan. 5, Greenbrier reported better-than-expected first-quarter earnings.
en_USEnglish